Management of Acute Myelogenous Leukemia in the Elderly

Acute myelogenous leukemia in the elderly.

Familial Acute Myelogenous Leukemia: Report of Three Cases

Acute myelogenous leukemia (AML) is a hematological malignancy, which accounts for about 15-25% of childhood's leukemia. Genetic factor is one of the most important predisposing elements in childhood acute leukemia, especially AML. In this case report, a rare presentation of familial AML is presented in three monozygotic triplets. Two were 10 months old, and the other one was 16 months old at p...

Treating the elderly patient with acute myelogenous leukemia.

Decisions regarding the optimal treatment of acute myelogenous leukemia in the elderly patient requires the consideration of multiple factors. Population-based studies have demonstrated that, for all age groups, aggressive therapy results in improved survival and quality of life when compared with palliative care. The optimal induction and postremission regimen for older patients has yet to be ...

Treating the Elderly Patient with Acute Myelogenous Leukemia

Among patients with acute myeloid leukemia (AML), treatment regimens and outcomes may differ among younger and older adults. Although there is no clear dividing line when considering age in AML, in most studies, "older adults" was defined as over age 60.The management of older patients with AML is a difficult challenge. Older adults are more likely to have comorbidities that can limit treatment...

Chronic Myelogenous Leukemia (CML) in the elderly

Published: June 1, 2014 Received: May 5, 2014 Accepted: May 6, 2014 Citation: Mediterr J Hematol Infect Dis 2014, 6(1): e2014037, DOI: 10.4084/MJHID.2014.037 This article is available from: http://www.mjhid.org/article/view/13434 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unre...